Gedeon Richter PLC (BUD:RICHTER)
Hungary · Delayed Price · Currency is HUF 12,800
-230 (-1.77%)
At close: Aug 13, 2026
Gedeon Richter Financials Overview
Financials in millions HUF. Fiscal year is January - December.
Millions HUF. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 925,049 | 928,962 | 857,545 | 805,158 | 802,755 | 630,595 |
Revenue Growth | 2.40% | 8.33% | 6.51% | 0.30% | 27.30% | 11.26% |
Gross Profit Gross Profit Growth | 622,425 | 629,944 | 577,462 | 521,324 | 460,464 | 349,273 |
Operating Income Operating Income Growth | 304,883 | 299,411 | 254,679 | 221,153 | 190,653 | 135,351 |
Net Income Net Income Growth | 215,905 | 232,335 | 239,244 | 158,850 | 169,076 | 139,626 |
Earnings Per Share EPS Growth | 1180.33 | 1270.58 | 1307.23 | 859.72 | 907.39 | 750.65 |
EPS Growth | -2.25% | -2.80% | 52.05% | -5.25% | 20.88% | 33.35% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceuticals - Neuropsychiatry (CNS) Pharmaceuticals - Neuropsychiatry (CNS) Growth | 273,266 | 264,701 | 242,749 | 205,662 | 145,902 | - |
Pharmaceuticals - General Medicines (GM) Pharmaceuticals - General Medicines (GM) Growth | 236,114 | 249,534 | 250,712 | 226,888 | 225,916 | - |
Pharmaceuticals - Women's Healthcare (WHC) Pharmaceuticals - Women's Healthcare (WHC) Growth | 327,116 | 328,573 | 286,218 | 255,673 | 229,206 | - |
Pharmaceuticals - Biotechnology (BIO) Pharmaceuticals - Biotechnology (BIO) Growth | 69,926 | 64,157 | 54,014 | 46,201 | 41,185 | - |
Pharmaceuticals - Pharma Other Pharmaceuticals - Pharma Other Growth | 5,199 | 6,994 | 11,119 | 13,022 | 14,134 | - |
Other Other Growth | 24,102 | 25,581 | 24,977 | 70,874 | 164,287 | 7,150 |
Eliminations Eliminations Growth | -10,674 | -10,578 | -12,244 | -13,162 | -17,875 | -15,787 |
Total Total Growth | 925,049 | 928,962 | 857,545 | 805,158 | 802,755 | 630,595 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 285,189 | 258,164 | 136,621 | 87,404 | 109,311 | 59,867 |
Total Debt Total Debt Growth | 94,972 | 97,652 | 104,865 | 86,970 | 85,081 | 84,289 |
Net Cash (Debt) Net Cash Growth | 190,217 | 160,512 | 31,756 | 434 | 24,230 | -24,422 |
Net Cash Growth | 238.54% | 405.45% | 7217.05% | -98.21% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1039.90 | 877.80 | 173.51 | 2.35 | 130.04 | -131.30 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 297,814 | 276,403 | 279,369 | 123,670 | 185,996 | 139,904 |
Capital Expenditures CapEx Growth | -39,833 | -42,579 | -52,927 | -61,960 | -59,231 | -46,127 |
Free Cash Flow Free Cash Flow Growth | 257,981 | 233,824 | 226,442 | 61,710 | 126,765 | 93,777 |
Free Cash Flow Growth | 13.08% | 3.26% | 266.94% | -51.32% | 35.18% | -2.94% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 67.29% | 67.81% | 67.34% | 64.75% | 57.36% | 55.39% |
Operating Margin | 32.96% | 32.23% | 29.70% | 27.47% | 23.75% | 21.46% |
Pretax Margin | 28.58% | 30.65% | 32.78% | 21.31% | 20.64% | 23.24% |
Profit Margin | 23.34% | 25.01% | 27.90% | 19.73% | 21.06% | 22.14% |
FCF Margin | 27.89% | 25.17% | 26.41% | 7.66% | 15.79% | 14.87% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 508.000 | - | 508.000 | 431.983 | 390.000 | 225.000 |
Dividend Per Share Growth | 28.88% | - | 17.60% | 10.76% | 73.33% | 0% |
Dividend Yield | 3.90% | - | 5.42% | 5.73% | 5.71% | 3.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.84 | 7.74 | 7.91 | 10.24 | 9.12 | 11.60 |
Forward PE | 8.12 | 6.69 | 6.99 | 8.49 | 7.56 | 12.98 |
P/FCF Ratio | 9.05 | 7.70 | 8.36 | 26.37 | 12.17 | 17.27 |
PS Ratio | 2.52 | 1.94 | 2.21 | 2.02 | 1.92 | 2.57 |